Label: MELEYA- norethindrone tablet

  • NDC Code(s): 70700-317-84, 70700-317-85
  • Packager: Xiromed LLC
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated March 6, 2025

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION
    Rx only - Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases.
  • DESCRIPTION
    Meleya - Each tablet contains 0.35 mg norethindrone. Inactive ingredients include corn starch, D&C Yellow No. 10, ethyl cellulose, lactose anhydrous, magnesium stearate, microcrystalline ...
  • CLINICAL PHARMACOLOGY
    1. Mode of Action - Meleya progestin-only oral contraceptives prevent conception by suppressing ovulation in approximately half of users, thickening the cervical mucus to inhibit sperm ...
  • INDICATIONS AND USAGE
    1. Indications - Progestin-only oral contraceptives are indicated for the prevention of pregnancy. 2. Efficacy - If used perfectly, the first-year failure rate for progestin-only oral contraceptives ...
  • CONTRAINDICATIONS
    Progestin-only oral contraceptives (POPs) should not be used by women who currently have the following conditions: Known or suspected pregnancy - Known or suspected carcinoma of the ...
  • WARNINGS
    Cigarette smoking increases the risk of serious cardiovascular disease. Women who use oral contraceptives should be strongly advised not to smoke. Norethindrone tablets do not contain estrogen ...
  • PRECAUTIONS
    1. General - Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases. 2. Physical Examination and Follow-up - It is ...
  • ADVERSE REACTIONS
    Adverse reactions reported with the use of POPs include: Menstrual irregularity is the most frequently reported side effect. Frequent and irregular bleeding are common, while long duration of ...
  • OVERDOSAGE
    There have been no reports of serious ill effects from overdosage, including ingestion by children.
  • DOSAGE AND ADMINISTRATION
    To achieve maximum contraceptive effectiveness, Meleya must be taken exactly as directed. One tablet is taken every day, at the same time. Administration is continuous, with no interruption ...
  • HOW SUPPLIED
    Meleya (Norethindrone Tablets USP, 0.35 mg) is available in a blister pack containing 28 yellow, round, flat faced, beveled edge tablets, debossed 220 on one side and other side plain. NDC ...
  • PATIENT PACKAGE INSERT
    DETAILED PATIENT LABELING - Meleya™ (Norethindrone Tablets, USP, 0.35 mg) This product (like all oral contraceptives) is used to prevent pregnancy. It does not protect against HIV infection ...
  • Instructions For Using your Blister Pack for the 28 Tablets
    Please Read Me! Save these Instructions. It’s best to take your first POP on the first day of your menstrual period (Day 1 Start). If you use a Day 1 Start, you are protected from becoming ...
  • PACKAGE LABEL. PRINCIPAL DISPLAY PANEL
    3s Carton
  • INGREDIENTS AND APPEARANCE
    Product Information